The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Lupin Australia Pty Limited
Regulatory activities for this sponsor.
Loading...
Sponsor content
550 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOLVAPTAN GH tolvaptan 30 mg + 60 mg tablet blister composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOLVAPTAN GH tolvaptan 15 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOLVAPTAN LUPIN tolvaptan 15 mg + 45 mg tablet blister composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOLVAPTAN LUPIN tolvaptan 30 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOLVAPTAN LUPIN tolvaptan 15 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOLVAPTAN LUPIN tolvaptan 30 mg + 60 mg tablet blister composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOLVAPTAN LUPIN tolvaptan 30 mg + 90 mg tablet blister composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARX-MOXONIDINE moxonidine 400 microgram film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARX-MOXONIDINE moxonidine 200 microgram film-coated tablet blister pack.
-
Prescription medicine registrationActive ingredients: ganirelix.